Medicare, Medicaid Drug Payment Models Get Designated Team At CMMI

CMS’ innovation center creates new division to test alternative payment models, including likely new approaches for accelerated approval drugs and multi-state outcomes-based payment arrangements for cell and gene therapy in Medicaid.